Condition: Patient with Refractory Hodgkin's Lymphoma on Pembrolizumab, Infected with SARS-CoV-2
Journal: British journal of haematology
Treatment Used: Two Cycles of Adriamycin/Bleomycin/Vinblastine/Dacarbazine (ABVD) with Escalation to Bleomycin/Etoposide/Adriamycin/Cyclophosphamide/Vincristine/Procarbazine/Prednisolone (escBEACOPP) for Four Cycles